Achondroplasia is a genetic condition driven by FGFR3 that affects more than stature alone
ADQUEY’s approval opens the door to a new alternative for millions of Americans struggling with atopic dermatitis
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
The therapy is currently completing Phase 1 clinical trials in renal cell carcinoma and non-small cell lung cancer
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
CSPC will receive an upfront $1.2 billion from AstraZeneca for access to eight programmes, AI molecular design capabilities, and the LiquidGel platform
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
Subscribe To Our Newsletter & Stay Updated